ImClone Investigational Site

Columbus, Ohio 43235

0 studies enrolling now · 6 studies all time

What they study most

Adipocytic Sarcoma, Breast Cancer, Carcinoma, Colorectal Cancer, Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET), Leiomyosarcoma, Metastatic Breast Cancer, Myeloid Leukemia, Neuroendocrine Tumors, Rhabdomyosarcoma, Synovial Sarcoma

Studies at this site

• Study of IMC-EB10 in Participant With Leukemia — Stopped early
• A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer — Completed
• Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients — Completed
• A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma — Completed
• A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed